Engaging male partners in women's microbicide use: Evidence from clinical trials and implications for future research and microbicide introduction

Journal of the International AIDS Society

Volumn 17, Issue 3, 2014, Pages

  Lanham, Michele ^a   Wilcher, Rose ^a   Montgomery, Elizabeth T ^b   Pool, Robert ^c   Schuler, Sidney ^a   Lenzi, Rachel ^a   Friedland, Barbara ^d  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d POPULATION COUNCIL   (United States)

Author keywords

Gender relations; HIV; Microbicides; Partner communication; Qualitative research

Indexed keywords

MICROBICIDE; ANTIINFECTIVE AGENT;

ACCESS TO INFORMATION; ARTICLE; AWARENESS; EDUCATION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; KENYA; MALE; MASS MEDIUM; PATIENT COUNSELING; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); SOUTH AFRICA; TANZANIA; ADULT; DISEASE TRANSMISSION; DRUG UTILIZATION; HEALTH EDUCATION; HIV INFECTIONS; INTERVIEW; INTRAVAGINAL DRUG ADMINISTRATION; PATIENT ATTITUDE; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; SEXUALITY; YOUNG ADULT;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-INFECTIVE AGENTS; DISEASE TRANSMISSION, INFECTIOUS; DRUG UTILIZATION; FEMALE; HEALTH EDUCATION; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; KENYA; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; SEXUAL PARTNERS; SOUTH AFRICA; TANZANIA; YOUNG ADULT;

EID: 84915748936     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.17.3.19159     Document Type: Article

References (51)

1. Stein ZA. HIV prevention: the need for methods women can use. Am J Public Health. 1990;80(4):460-2.
2. Whitehead SJ, McLean C, Chaikummao S, Braunstein S, Utaivoravit W, van de Wijgert JH, et al. Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand. PLoS One. 2011;6(9):e14831.
3. Pool R, Whitworth JA, Green G, Mbonye AK, Harrison S, Wilkinson J, et al. An acceptability study of female-controlled methods of protection against HIV and STDs in south-western Uganda. Int J STD & AIDS. 2000;11(3):162-7.
4. Hoffman S, Morrow KM, Mantell JE, Rosen RK, Carballo-Dieguez A, Gai F. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial. Arch Sex Behav. 2010; 39(3):748-60.
5. Rosen RK, Morrow KM, Carballo-Dieguez A, Mantell JE, Hoffman S, Gai F, et al. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. J Women's Health. 2008;17(3):383-92.
6. van der Straten A, Montgomery ET, Cheng H, Wegner L, Masenga G, von Mollendorf C, et al. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS Behav. 2012;16(7):1775-86.
7. Montgomery ET, Cheng H, van der Straten A, Chidanyika AC, Lince N, Blanchard K, et al. Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa. AIDS Behav. 2010;14(3):629-38.
8. Gafos M, Mzimela M, Sukazi S, Pool R, Montgomery C, Elford J. Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use. Cult Health Sex. 2010;12(8):929-42.
9. Green G, Pool R, Harrison S, Hart GJ, Wilkinson J, Nyanzi S, et al. Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda. Soc Sci Med. 2001;52(4):585-98.
10. Montgomery CM, Gafos M, Lees S, Morar NS, Mweemba O, Ssali A, et al. Re-framing microbicide acceptability: findings from the MDP301 trial. Cult Health Sex. 2010;12(6):649-62.
11. Sahin-Hodoglugil NN, van der Straten A, Cheng H, Montgomery ET, Kacanek D, Mtetwa S, et al. Degrees of disclosure: a study of women's covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. Soc Sci Med. 2009;69(10):1547-55.
12. Woodsong C. Covert use of topical microbicides: implications for acceptability and use. Int Fam Plan Perspect. 2004;30(2):94-8.
13. Montgomery ET, van der Straten A, Chidanyika A, Chipato T, Jaffar S, Padian N. The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2011;15(5):959-69.
14. Salter ML, Go VF, Celentano DD, Diener-West M, Nkhoma CM, Kumwenda N, et al. The role of men in women's acceptance of an intravaginal gel in a randomized clinical trial in Blantyre, Malawi: a qualitative and quantitative analysis. AIDS Care. 2008;20(7):853-62.
15. Mngadi KT, Maarschalk S, Grobler AC, Mansoor LE, Frohlich JA, Madlala B, et al. Disclosure of microbicide gel use to sexual partners: influence on adherence in the CAPRISA 004 trial. AIDS Behav. 2014;18(5):849-54.
16. Greene E, Batona G, Hallad J, Johnson S, Neema S, Tolley EE. Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India. Cult Health Sex. 2010;12(7):739-54.
17. Muchomba FM, Gearing RE, Simoni JM, El-Bassel N. State of the science of adherence in pre-exposure prophylaxis and microbicide trials. J Acquir Immune Defic Syndr. 2012;61(4):490-8.
18. Woodsong C, MacQueen K, Amico KR, Friedland B, Gafos M, Mansoor L, et al. Microbicide clinical trial adherence: insights for introduction. J Int AIDS Soc. 2013;16:18505.
19. Woodsong C, Macqueen K, Namey E, Sahay S, Morar N, Mlingo M, et al. Women's autonomy and informed consent in microbicides clinical trials. J Empir Res Hum Res Ethics. 2006;1(3):11-26.
20. Pistorius AG, van de Wijgert JH, Sebola M, Friedland B, Nagel E, Bokaba C, et al. Microbicide trials for preventing HIV/AIDS in South Africa: phase II trial participants' experiences and psychological needs. SAHARA J. 2004;1(2):78-86.
21. Marlow HM, Tolley EE, Kohli R, Mehendale S. Sexual communication among married couples in the context of a microbicide clinical trial and acceptability study in Pune, India. Cult Health Sex. 2010;12(8):899-912.
22. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010; 329(5996):1168-74.
23. Barker G, Ricardo C, Nascimento M. Engaging men and boys in changing gender-based inequity in health: evidence from programme interventions. Geneva: World Health Organization; 2007.
24. Shattuck D, Kerner B, Gilles K, Hartmann M, Ng'ombe T, Guest G. Encouraging contraceptive uptake by motivating men to communicate about family planning: the Malawi Male Motivator project. Am J Public Health. 2011;101(6):1089-95.
25. Becker S. Couples and reproductive health: a review of couple studies. Stud Fam Plan. 1996;27(6):291-306.
26. World Health Organization. Male involvement in the prevention of mother-to-child transmission of HIV. Geneva: World Health Organization; 2012.
27. Aluisio A, Richardson BA, Bosire R, John-Stewart G, Mbori-Ngacha D, Farquhar C. Male antenatal attendance and HIV testing are associated with decreased infant HIV infection and increased HIV-free survival. J Acquir Immune Defic Syndr. 2011;56(1):76-82.
28. McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329-37.
29. Montgomery CM, Pool R. Critically engaging: integrating the social and the biomedical in international microbicides research. J Int AIDS Soc. 2011; 14(Suppl 2):S4.
30. Montgomery CM, Watts C, Pool R. HIV and dyadic intervention: an interdependence and communal coping analysis. PLoS One. 2012;7(7):e40661.
31. Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS One. 2010;5(7):e11600.
32. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372 (9654):1977-87.
33. Abbott S, Friedland B, Katzen L. Health concerns and HIV risk perception as motives to join a clinical trial. 36th Annual Psychosocial Workshop; 2007 Apr 15-16; New Orleans, Louisiana.
34. Abbott S, Friedland B, Katzen L, de Kock A, Madiba S, Cishe S. Decision making and the influences of others in the informed consent process: a qualitative investigation in the Phase 3 study of Carraguard®. International Microbicides Conference; 2008 Feb 24-27; New Dehli, India.
35. Abbott S, Friedland B, Katzen L, Madiba S, de Kock A, Cishe S. What motivates women to enroll in microbicide clinical trials: results from the Phase 3 Carraguard® Trial. XVII Annual International AIDS Conference; 2010 Aug 3-8; Mexico City, Mexico.
36. Katzen L, Friedland B, Abbott S, de Kock A, Madiba S, Cishe S. Qualitative evaluation of the informed consent process in the Phase 3 Carraguard® Efficacy Trial: study staff experiences and recommendations for future trials. International Microbicides Conference; 2008 Feb 24-27; New Dehli, India.
37. Madiba S, Friedland B, Abbott S, Katzen L, de Kock A, Cishe S. Male partner involvement in the Carraguard® Phase 3 Trial: data from a qualitative study of the informed consent process. International Microbicides Conference; 2008 Feb 24-27; New Dehli, India.
38. Abbott S, Morar N, Madiba S, Katzen L, Phillip J, Mokgatle-Nthabu M, et al. Microbicides acceptability: the influence of social and cultural norms, interpersonal relations and sexual socialization. International Microbicides Conference; 2010 May 23; Pittsburgh, PA.
39. de Kock A, Abbott S, Morar N, Friedland B, Mtimkulu V, Cishe S, et al. Exploring microbicide acceptability in terms of socio-cultural norms, relationships and product attributes in the Carraguard® Phase 3 Trial in South Africa. XVII Annual International AIDS Conference; 2008 Aug 3-8; Mexico City, Mexico.
40. Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, Nakabiito C, et al. Preexposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine or vaginal tenofovir gel in the VOICE study (MTN 003). 20th Conference on Retroviruses and Opportunistic Infections; 2013 Mar 3-6; Atlanta, GA.
41. van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, et al. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS One. 2014;9(2):e89118.
42. Cohen CR, Brown J, Moscicki AB, Bukusi EA, Paull JR, Price CF, et al. A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel(R)) in healthy young women administered twice daily for 14 days. PLoS One. 2011;6(1):e16258.
43. Headley J, Baumgartner JN, Kaaya S, Minja A, Kalungula H, Bangapi D, et al. Adolescent and young women's acceptability and use of a proxy microbicide gel or pill in a mock trial in Tanzania. 4th International Workshop on HIV & Women; 2014 Jan 13-14; Washington, DC.
44. Tolley E, Kaaya S, Kaale A, Kalungula H, Headley J, Baumgartner JN. Do adolescents under 18 years old warrant inclusion in HIV prevention clinical research? Comparing sexual risk patterns of adolescent and young adult women in a mock trial in Tanzania. XIX International AIDS Conference; 2012 Jul 22-27; Washington, DC.
45. Baumgartner JN, Kaaya S, Kaale A, Headley J, Tolley E. Domestic violence among adolescents and young women in HIV prevention research in Tanzania: participant experiences and measurement issues. XIX International AIDS Conference; 2012 Jul 22-27; Washington, DC.
46. Tolley E, Kaaya S, Bangapi D, Minja A, Headley J, Kaale A, et al. Feasibility of recruiting adolescent women into a mock HIV prevention trial. XIX International AIDS Conference; 2012 Jul 22-27; Washington, DC.
47. Tolley E, Baumgartner JN, Kaaya S, Sastry J, Headley J. Adolescent sexual risk and perceived need for PrEP: paving the way for their future participation in HIV prevention trials. International Microbicides Conference; 2012 Apr 15-18; Sydney, Australia.
48. Baumgartner JN, Tolley E, Kaaya S, Sastry J, Headley J. Adolescent and community perspectives on microbicide trial participation in Tanzania and India. International Microbicides Conference; 2012 Apr 15-18; Sydney, Australia.
49. Sastry J, Tolley E. Research on adolescent sex: to do or not to do. International Microbicides Conference; 2012 Apr 15-18; Sydney, Australia.
50. Venables E, Stadler J. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research. Cult Health Sex. 2012;14(2):181-94.
51. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370 (9583):251-61.